论文信息 - Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals - 字舞流文

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals

A. Hill | R. Tayyem | Giten Khwairakpam | S. Nath | Sherine Helmy | J. Freeman | Mohammed Khalil Mohammed | Loai Tahat | Ismahane Benbitour

[1] A. Hill,et al. High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C , 2017, Journal of virus eradication.

[2] T. Asselah,et al. ENDURANCE-3: safety and efficacy of glecaprevir/pibrentasvir compared to sofosbuvir plus daclatasvir in treatment-naïve HCV genotype 3-infected patients without cirrhosis , 2017 .